
The second of a phase 3 study examining MDMA-AT just completed its final participant visit.

Ms Kuntz is the assistant managing editor of Psychiatric Times.

The second of a phase 3 study examining MDMA-AT just completed its final participant visit.

We may be one step closer to nonprescription naloxone.

ADHD is an all-day affair, and treating it in an adult population can be difficult.

What is the impact of antipsychotic side effects on medication adherence?

A single dose of psilocybin could help patients with treatment-resistant depression, according to a new study.

Individuals with a psychotic disorder are 2.5 times more likely than those without one to develop dementia.

According to new research, treating depression in older adults could decrease risk of dementia by 51%.

What scares mental health clinicians? We asked, and these brave individuals replied…

How can PMHNP consults with law enforcement reduce involuntary transfers and other unwanted outcomes?

Does the YOI intervention improve mental health workers’ insomnia? Research says yes.

Recent research determined the medications modafinil, atomoxetine, and guanfacine negatively impact bones.

Did you miss the 2022 Annual Psychiatric Times™ World CME Conference? We've got you covered.

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

A new poll sought to understand the public’s beliefs about mental health and suicide prevention. Here are the results.

The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.

For the first time, the USPSTF is recommending anxiety screening for adults under 65.

Reading 1 story a day might help those living with suicidal thoughts and behaviors.

The FDA has accepted the NDA for aripiprazole 2-month, ready-to-use, long-acting injectable.

Long-acting injectable haloperidol decanoate may work as a treatment for Adderall-induced persistent psychosis.

A new study finds mood shifts and alcohol-related cues affect men and women differently in terms of alcohol cravings.

The National Commission on Correctional Health Care has issued a new directive for trauma-responsive care for children and adolescents in correctional facilities.

Suicide Prevention Week is September 4-10. Are you ready?

New data shows a decrease in life expectancy in the United States. Here’s why.

This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.

The first patient has been dosed in the phase 2b dose-optimization trial of a pharmaceutically optimized form of LSD for the treatment of generalized anxiety disorder.

One researcher shares his evidence for the usage of psilocybin in psychiatry.

Dextromethorphan HBr -bupropion HCl extended-release tablets for the treatment of major depressive disorder just became FDA approved.

What are the long term psychiatric and neuropsychiatric complications of COVID-19?

Treating women of reproductive age who have depression can be difficult. Here’s an overview on the subject from the 2022 Annual Psychiatric Times™ World CME Conference.

Can we inherit our parents’ trauma? Research points to yes.